Pharma Finance and Investment News
Shutterstock
Work Begins on £42m Specialist UK Lab Space
Bruntwood SciTech has commenced construction on a £42m, 125,000 sq ft specialist lab and office workspace at the Citylabs cluster to strengthen the internationally significant health innovation campus. Read more
19 Sep 2023
Pharma Manufacturing News + Pharma Finance and Investment News
Shutterstock
EverImmune Secure €3.5 million in Financing from Bpifrance
EverImmune announces that it has secured €3.46 million ($3.41M) in funding from Bpifrance, under the ‘Innovation in biotherapeutics’ scheme. Read more
19 Sep 2023
Pharma Manufacturing News + Pharma Finance and Investment News
Shutterstock
Poolbeg Pharma Publish Interim Results From Last Six Months
Poolbeg Pharma , a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announces its unaudited interim results for the six months to 30 June 2023. Read more
19 Sep 2023
Pharma Manufacturing News + Pharma Finance and Investment News
Shutterstock
Broken String Biosciences Closes $15M Series A Funding Round
Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, have announced that it has closed a $15 million Series A investment round. Read more
18 Sep 2023
Pharma Manufacturing News + Pharma Finance and Investment News
Astellas to Invest More than €330 Million in a New State-of-the-Art Facility in Ireland
Astellas Pharma Inc recently announced its intention to submit a planning application to build a new state-of-the-art facility, at an approximate cost of €330 million in Tralee, Co. Kerry. Read more
18 Sep 2023
Pharma Manufacturing News + Pharma Finance and Investment News
SOMAÍ Pharmaceuticals Receive EU-GMP Certification and Raises €5 million
SOMAÍ Pharmaceuticals announces that it has received authorisation for its facility from the Portuguese Health Authority INFRAMED and has successfully raised €5 million of new capital to fund its ambitious growth plans. Read more
18 Sep 2023
Pharma Manufacturing News + Pharma Finance and Investment News
Shutterstock
Idorsia Reacquires the Worldwide Rights to Aprocitentan
Idorsia Ltd recently announced that it has entered into an agreement with Janssen Biotech Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, for the return of rights for aprocitentan to Idorsia. Read more
8 Sep 2023
Pharma Manufacturing News + Pharma Finance and Investment News
Sonrai Analytics and Cancer Research Horizons Join Forces
Sonrai Analytics and Cancer Research Horizons have formed a partnership to drive precision medicine innovation. Read more
6 Sep 2023
Pharma Manufacturing News + Pharma Finance and Investment News
CN Bio and LifeNet Health LifeSciences Partner
CN Bio and LifeNet Health LifeSciences have announced a strategic partnership to supply validated primary human cells for use with CN Bio’s PhysioMimix OOC range of MPS. Read more
6 Sep 2023
Pharma Manufacturing News + Pharma Finance and Investment News
Shutterstock
Otsuka and Astex Announce the European Commission has Approved INAQOVI
Otsuka Pharmaceutical Europe Ltd. and Astex Pharmaceuticals, Inc. have announce that the European Commission (EC) has approved INAQOVI. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
Daiichi and AstraZeneca Breast Cancer Drug Hits Goal
Positive high-level results from the TROPION-Breast01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant and clinically meaningful improvement. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Shutterstock
Samsung Biologics Announce Agreement with Bristol Myers Squibb to Manufacture an Antibody Cancer Drug Substance
Samsung Biologics announced today a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance. Read more
22 Sep 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
TurboFil Expands Development and Demonstration Facility
TurboFil Packaging Machines LLC has substantially expanded the product development and demonstration space at its Mount Vernon, NY headquarters. Read more
22 Sep 2023
Shutterstock
Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment
A partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive disorder. Read more
22 Sep 2023
Shutterstock
2San Partners With Phoenix Healthcare To Launch Self Diagnostic Tests In UK
2San is partnering with Phoenix Healthcare to allow independent pharmacies to stock an increased range of rapid self-diagnostic products. Read more
21 Sep 2023
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Wickham Laboratories Ltd
Wickham Laboratories is a leading contract provider of microbiological services for Pharmaceutical quality control, research and product development testing Read more
